Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by APAPP. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by APAPP or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

What's new in PAH in 2024

34:10
 
Share
 

Manage episode 442941648 series 3480755
Content provided by APAPP. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by APAPP or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Dr. Melissa Wilson discusses new treatments in the field of pulmonary hypertension in 2024, focusing on Sotatercept and combination therapy with Opsynvi. Dr. Wilson emphasizes the importance of patient selection and individualized treatment plans. She also discusses the initiation and monitoring of these therapies, as well as potential side effects and patient adherence.

Send us a text

Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA
Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.com
Follow us on:

  • Instagram @pulmapps
  • Twitter@pulmapp
  • Facebook @association of pulmonary advance practice providers.
  continue reading

24 episodes

Artwork
iconShare
 
Manage episode 442941648 series 3480755
Content provided by APAPP. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by APAPP or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Dr. Melissa Wilson discusses new treatments in the field of pulmonary hypertension in 2024, focusing on Sotatercept and combination therapy with Opsynvi. Dr. Wilson emphasizes the importance of patient selection and individualized treatment plans. She also discusses the initiation and monitoring of these therapies, as well as potential side effects and patient adherence.

Send us a text

Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA
Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.com
Follow us on:

  • Instagram @pulmapps
  • Twitter@pulmapp
  • Facebook @association of pulmonary advance practice providers.
  continue reading

24 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play